COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,017 Articles (22,627 medRxiv, 8,390 bioRxiv)

Most recent first Previous |  Page 2538: Articles 25371-25380  | Next

Factors Associated with Mental Health Outcomes in Oman during COVID19: Frontline vs Non-frontline Healthcare Workers
Alshekaili, M., Hassan, W., Al Said, N., Alsulaimani, F., Jayapal, S. K., Al-Mawali, A., Chan, M. F., Mahadevan, S., Al-Adawi, S.
10.1101/2020.06.23.20138032 — Posted: 2020-06-23
Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS CoV 2
MacGowan, A. P., Hamilton, F., Bayliss, M., Read, L., Attwood, M., Noel, A., Grier, S., Morley, A., Arnold, D., maskell, N.
10.1101/2020.06.23.20137992 — Posted: 2020-06-23 Discussion: Onsite | Offsite
Understanding the Bias between the Number of Confirmed Cases and Actual Number of Infections in the COVID-19 Pandemic
Chen, X., Hazra, D. K.
10.1101/2020.06.22.20137208 — Posted: 2020-06-23
Vitamin D insufficiency and deficiency and mortality from respiratory diseases in a cohort of older adults: potential for limiting the death toll during and beyond the COVID-19 pandemic
Brenner, H., Holleczek, B., Schoettker, B.
10.1101/2020.06.22.20137299 — Posted: 2020-06-23
The impact of asymptomatic COVID-19 infections on future pandemic waves
Fox, S. J., Pasco, R., Tec, M., Du, Z., Lachmann, M., Scott, J., Meyers, L. A.
10.1101/2020.06.22.20137489 — Posted: 2020-06-23
Retrospective Methodology to Estimate Daily Infections from Deaths (REMEDID) in COVID-19: the Spain case study
Garcia-Garcia, D., Vigo, M. I., Fonfria, E. S., Herrador, Z., Navarro, M., Bordehore, C.
10.1101/2020.06.22.20136960 — Posted: 2020-06-23
Universal scaling law for COVID-19 propagation in urban centers
Cardoso, B.-H. F., Goncalves, S.
10.1101/2020.06.22.20137604 — Posted: 2020-06-23
A Macroeconomic SIR Model for COVID-19
Bayraktar, E., Cohen, A., Nellis, A.
10.1101/2020.06.22.20137711 — Posted: 2020-06-23
Spectrum of innate and adaptive immune response to SARS CoV 2 infection across asymptomatic, mild and severe cases; a longitudinal cohort study
Carsetti, R., Zaffina, S., Piano Mortari, E., Terreri, S., Corrente, F., Capponi, C., Palomba, P., Mirabella, M., Cascioli, S., Palange, P., Cuccaro, I., Milito, C., Zumla, A., Maeurer, M., Camisa, V., Vinci, M. R., Santoro, A., Cimini, E., Marchioni, L., Nicastri, E., Palmieri, F., Agrati, C., Ippolito, G., Porzio, O., Concato, C., Onetti Muda, A., Raponi, M., Quintarelli, C., Quinti, I., Locatelli, F.
10.1101/2020.06.22.20137141 — Posted: 2020-06-23 Discussion: Onsite
Derivation and Validation of Clinical Prediction Rule for COVID-19 Mortality in Ontario, Canada
Fisman, D., Greer, A. L., Tuite, A.
10.1101/2020.06.21.20136929 — Posted: 2020-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).